Tweedy Browne Co. Novartis Ag Transaction History

Tweedy, Browne CO LLC

$2.03 Billion
Q3 2024

A detailed history of Tweedy Browne Co. (Tweedy, Browne CO LLC) transactions in Novartis Ag stock. As of the latest transaction made, Tweedy, Browne CO LLC holds 85,347 shares of NVS stock, worth $8.4 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

85,347

Previous 87,606 2.58%

Holding current value

$8.4 Million

Previous $9.33 Million 5.25%

% of portfolio

0.48%

Previous 0.44%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$106.13 - $120.89 $239,747 - $273,090	-2,259 Reduced 2.58%	85,347 $9.82 Million
Q2 2024 Aug 12, 2024	SELL	$92.57 - $107.37 $170,328 - $197,560	-1,840 Reduced 2.06%	87,606 $9.33 Million
Q1 2024 May 06, 2024	SELL	$95.27 - $108.47 $111,751 - $127,235	-1,173 Reduced 1.29%	89,446 $8.65 Million
Q4 2023 Feb 13, 2024	SELL	$92.27 - $101.54 $396,484 - $436,317	-4,297 Reduced 4.53%	90,619 $9.15 Million
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $107,992 - $119,848	-1,140 Reduced 1.19%	94,916 $9.67 Million
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $163,945 - $185,900	-1,772 Reduced 1.81%	96,056 $9.69 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $86,272 - $100,049	-1,078 Reduced 1.09%	97,828 $9 Million
Q4 2022 Feb 09, 2023	SELL	$75.55 - $92.52 $136,216 - $166,813	-1,803 Reduced 1.79%	98,906 $8.97 Million
Q3 2022 Nov 15, 2022	BUY	$74.61 - $87.26 $170,036 - $198,865	2,279 Added 2.32%	100,709 $7.66 Million
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $282,464 - $328,875	-3,508 Reduced 3.44%	98,430 $8.32 Million
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $332,536 - $376,163	-4,151 Reduced 3.91%	101,938 $8.95 Million
Q4 2021 Feb 10, 2022	SELL	$79.7 - $88.13 $405,752 - $448,669	-5,091 Reduced 4.58%	106,089 $9.28 Million
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $345,356 - $401,776	-4,223 Reduced 3.66%	111,180 $9.09 Million
Q2 2021 Aug 12, 2021	SELL	$85.24 - $94.15 $1.05 Million - $1.16 Million	-12,301 Reduced 9.63%	115,403 $10.5 Million
Q1 2021 May 07, 2021	SELL	$83.5 - $98.47 $177,688 - $209,544	-2,128 Reduced 1.64%	127,704 $10.9 Million
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $795,611 - $962,336	-10,191 Reduced 7.28%	129,832 $12.3 Million
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $336,609 - $372,918	-4,098 Reduced 2.84%	140,023 $12.2 Million
Q2 2020 Aug 11, 2020	SELL	$80.93 - $91.1 $606,084 - $682,247	-7,489 Reduced 4.94%	144,121 $12.6 Million
Q1 2020 May 13, 2020	SELL	$70.67 - $99.01 $154,413 - $216,336	-2,185 Reduced 1.42%	151,610 $12.5 Million
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $113,450 - $128,272	-1,345 Reduced 0.87%	153,795 $14.6 Million
Q3 2019 Nov 01, 2019	SELL	$85.54 - $94.26 $352,339 - $388,256	-4,119 Reduced 2.59%	155,140 $13.5 Million
Q2 2019 Aug 05, 2019	SELL	$75.4 - $92.8 $312,533 - $384,656	-4,145 Reduced 2.54%	159,259 $14.5 Million
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $650,463 - $743,991	-8,636 Reduced 5.02%	163,404 $15.7 Million
Q4 2018 Feb 08, 2019	SELL	$73.66 - $82.02 $631,045 - $702,665	-8,567 Reduced 4.74%	172,040 $14.8 Million
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $288,243 - $333,413	-4,306 Reduced 2.33%	180,607 $15.6 Million
Q2 2018 Aug 03, 2018	SELL	$64.91 - $73.36 $176,749 - $199,759	-2,723 Reduced 1.45%	184,913 $14 Million
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $78,132 - $93,406	-1,110 Reduced 0.59%	187,636 $15.2 Million
Q4 2017 Feb 15, 2018	SELL	$72.33 - $77.64 $593,539 - $637,113	-8,206 Reduced 4.17%	188,746 $15.8 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $14.6 Million - $15.2 Million	196,952	196,952 $16.9 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track Tweedy Browne Co.'s Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tweedy, Browne CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tweedy, Browne CO LLC and Tweedy Browne Co. with notifications on news.

Account